Serveur d'exploration sur la musique en Sarre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation

Identifieur interne : 001099 ( Istex/Corpus ); précédent : 001098; suivant : 001100

Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation

Auteurs : D. J. Tobin

Source :

RBID : ISTEX:A29E36D2DF4EE53D92948B9C8EE481D49D1CD779

English descriptors

Abstract

Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides in vitro. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the in situ expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth. In toto, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.

Url:
DOI: 10.1111/j.0906-6705.2004.0212j.x

Links to Exploration step

ISTEX:A29E36D2DF4EE53D92948B9C8EE481D49D1CD779

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<author>
<name sortKey="Tobin, D J" sort="Tobin, D J" uniqKey="Tobin D" first="D. J." last="Tobin">D. J. Tobin</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, University of Bradford, Bradford, UK</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A29E36D2DF4EE53D92948B9C8EE481D49D1CD779</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.0906-6705.2004.0212j.x</idno>
<idno type="url">https://api.istex.fr/document/A29E36D2DF4EE53D92948B9C8EE481D49D1CD779/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001099</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001099</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<author>
<name sortKey="Tobin, D J" sort="Tobin, D J" uniqKey="Tobin D" first="D. J." last="Tobin">D. J. Tobin</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, University of Bradford, Bradford, UK</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Experimental Dermatology</title>
<idno type="ISSN">0906-6705</idno>
<idno type="eISSN">1600-0625</idno>
<imprint>
<publisher>Blackwell Publishing Ltd/Inc.</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<date type="published" when="2004-09">2004-09</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="569">569</biblScope>
<biblScope unit="page" to="569">569</biblScope>
</imprint>
<idno type="ISSN">0906-6705</idno>
</series>
<idno type="istex">A29E36D2DF4EE53D92948B9C8EE481D49D1CD779</idno>
<idno type="DOI">10.1111/j.0906-6705.2004.0212j.x</idno>
<idno type="ArticleID">EXD212J</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0906-6705</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>2department</term>
<term>3department</term>
<term>Acth</term>
<term>Activates</term>
<term>Adhesion</term>
<term>Adrenomedullin</term>
<term>Agonist</term>
<term>Allergic dermatitis</term>
<term>Anagen</term>
<term>Antimicrobial</term>
<term>Antioxidant</term>
<term>Apoptosis</term>
<term>Apoptotic</term>
<term>Atopic</term>
<term>Atopic dermatitis</term>
<term>Autoimmune</term>
<term>Basal</term>
<term>Bdnf</term>
<term>Biomedical</term>
<term>Biomedical sciences</term>
<term>Bmdcs</term>
<term>Bohm1</term>
<term>Boltzmann</term>
<term>Calcitonin</term>
<term>Calcitonin peptide</term>
<term>Capsaicin</term>
<term>Cell biology</term>
<term>Cgrp</term>
<term>Charite</term>
<term>Costimulatory molecules</term>
<term>Cutaneous</term>
<term>Cutaneous inflammation</term>
<term>Cytokine</term>
<term>Cytotoxicity</term>
<term>Dendricity</term>
<term>Dendritic</term>
<term>Dendritic cells</term>
<term>Dermal</term>
<term>Dermal microvascular</term>
<term>Dermatitis</term>
<term>Dermatology</term>
<term>Endocrine</term>
<term>Endogenous</term>
<term>Endothelial</term>
<term>Endothelial cells</term>
<term>Eosinophil</term>
<term>Epidermal</term>
<term>Epithelial</term>
<term>Extracellular</term>
<term>Fibre</term>
<term>Fibroblast</term>
<term>Follicle</term>
<term>Functional role</term>
<term>Glutamine</term>
<term>Hacat</term>
<term>Hacat cells</term>
<term>Hair follicle</term>
<term>Hair follicles</term>
<term>Hair growth</term>
<term>Hamburg</term>
<term>Hdmec</term>
<term>Healthy subjects</term>
<term>Homeostasis</term>
<term>Human hair follicle</term>
<term>Human sebocytes</term>
<term>Human skin</term>
<term>Hyperalgesia</term>
<term>Immune</term>
<term>Immune cells</term>
<term>Immune response</term>
<term>Immune system</term>
<term>Immunobiology</term>
<term>Immunohistochemistry</term>
<term>Immunomodulatory</term>
<term>Immunoreactivity</term>
<term>Important role</term>
<term>Inflammation</term>
<term>Inflammatory</term>
<term>Insr</term>
<term>Internal medicine</term>
<term>Intracellular</term>
<term>Intracellular calcium concentration</term>
<term>Keratinocyte</term>
<term>Keratinocytes</term>
<term>Kinase</term>
<term>Ligand</term>
<term>Ludwig boltzmann institute</term>
<term>Luger1</term>
<term>Lymphocyte</term>
<term>Mast cells</term>
<term>Mc1r</term>
<term>Mediator</term>
<term>Melanin</term>
<term>Melanocortin</term>
<term>Melanocortin receptors</term>
<term>Melanocyte</term>
<term>Melanogenesis</term>
<term>Melanoma</term>
<term>Melanoma cells</term>
<term>Melatonin</term>
<term>Microvascular</term>
<term>Mitf</term>
<term>Modulators</term>
<term>Mrna</term>
<term>Msc</term>
<term>Munster</term>
<term>Murine</term>
<term>Naltrexone</term>
<term>Nerve fibers</term>
<term>Nerve fibres</term>
<term>Nerve growth factor</term>
<term>Nervous system</term>
<term>Neuroendocrine</term>
<term>Neurogenic</term>
<term>Neurogenic inflammation</term>
<term>Neuron</term>
<term>Neuropeptide</term>
<term>Neuropeptides</term>
<term>Neurotrophic</term>
<term>Neurotrophic factor</term>
<term>Neurotrophin</term>
<term>Neurotrophins</term>
<term>Neutral endopeptidase</term>
<term>Nk1r</term>
<term>Nmda</term>
<term>Pacap</term>
<term>Papilla</term>
<term>Par2</term>
<term>Pathway</term>
<term>Peptide</term>
<term>Peripheral blood eosinophils</term>
<term>Pigmentation</term>
<term>Plasma membrane</term>
<term>Pomc</term>
<term>Pomc peptides</term>
<term>Present study</term>
<term>Proinflammatory</term>
<term>Pruritus</term>
<term>Receptor</term>
<term>Regulator</term>
<term>Rheumatoid arthritis</term>
<term>Schwann</term>
<term>Sebaceous</term>
<term>Sebaceous gland</term>
<term>Sebocytes</term>
<term>Sensitization</term>
<term>Sensory nerves</term>
<term>Sensory neurons</term>
<term>Somatostatin</term>
<term>Trafficking</term>
<term>Transgenic</term>
<term>Transgenic mice</term>
<term>Trpv1</term>
<term>Tumour</term>
<term>Upregulated</term>
<term>Upregulation</term>
<term>Uremic pruritus</term>
<term>Urocortin</term>
<term>Vanilloid</term>
<term>Vasoactive</term>
<term>Vellus hair follicles</term>
<term>Wound healing</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides in vitro. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the in situ expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth. In toto, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>receptor</json:string>
<json:string>dermatology</json:string>
<json:string>follicle</json:string>
<json:string>keratinocytes</json:string>
<json:string>cutaneous</json:string>
<json:string>melanocyte</json:string>
<json:string>fibroblast</json:string>
<json:string>peptide</json:string>
<json:string>munster</json:string>
<json:string>mc1r</json:string>
<json:string>immune</json:string>
<json:string>pathway</json:string>
<json:string>inflammation</json:string>
<json:string>neuropeptides</json:string>
<json:string>melanoma</json:string>
<json:string>cgrp</json:string>
<json:string>epidermal</json:string>
<json:string>neurogenic</json:string>
<json:string>pomc</json:string>
<json:string>agonist</json:string>
<json:string>bdnf</json:string>
<json:string>dermatitis</json:string>
<json:string>2department</json:string>
<json:string>neuropeptide</json:string>
<json:string>dermal</json:string>
<json:string>capsaicin</json:string>
<json:string>pruritus</json:string>
<json:string>fibre</json:string>
<json:string>human skin</json:string>
<json:string>kinase</json:string>
<json:string>nk1r</json:string>
<json:string>melatonin</json:string>
<json:string>neurotrophins</json:string>
<json:string>intracellular</json:string>
<json:string>pigmentation</json:string>
<json:string>melanocortin</json:string>
<json:string>apoptosis</json:string>
<json:string>eosinophil</json:string>
<json:string>glutamine</json:string>
<json:string>mrna</json:string>
<json:string>hacat</json:string>
<json:string>microvascular</json:string>
<json:string>neurogenic inflammation</json:string>
<json:string>sebocytes</json:string>
<json:string>upregulation</json:string>
<json:string>trpv1</json:string>
<json:string>tumour</json:string>
<json:string>atopic</json:string>
<json:string>cytokine</json:string>
<json:string>murine</json:string>
<json:string>neuron</json:string>
<json:string>mediator</json:string>
<json:string>sensitization</json:string>
<json:string>calcitonin</json:string>
<json:string>inflammatory</json:string>
<json:string>luger1</json:string>
<json:string>atopic dermatitis</json:string>
<json:string>proinflammatory</json:string>
<json:string>somatostatin</json:string>
<json:string>endothelial cells</json:string>
<json:string>dendritic</json:string>
<json:string>3department</json:string>
<json:string>endothelial</json:string>
<json:string>urocortin</json:string>
<json:string>immunohistochemistry</json:string>
<json:string>cutaneous inflammation</json:string>
<json:string>vanilloid</json:string>
<json:string>hair follicle</json:string>
<json:string>sebaceous</json:string>
<json:string>pomc peptides</json:string>
<json:string>cell biology</json:string>
<json:string>melanin</json:string>
<json:string>neurotrophin</json:string>
<json:string>par2</json:string>
<json:string>melanogenesis</json:string>
<json:string>upregulated</json:string>
<json:string>nmda</json:string>
<json:string>hacat cells</json:string>
<json:string>papilla</json:string>
<json:string>pacap</json:string>
<json:string>immunoreactivity</json:string>
<json:string>sensory neurons</json:string>
<json:string>sensory nerves</json:string>
<json:string>cytotoxicity</json:string>
<json:string>naltrexone</json:string>
<json:string>msc</json:string>
<json:string>basal</json:string>
<json:string>schwann</json:string>
<json:string>immunobiology</json:string>
<json:string>anagen</json:string>
<json:string>antimicrobial</json:string>
<json:string>antioxidant</json:string>
<json:string>trafficking</json:string>
<json:string>calcitonin peptide</json:string>
<json:string>immune cells</json:string>
<json:string>transgenic</json:string>
<json:string>neurotrophic</json:string>
<json:string>hamburg</json:string>
<json:string>vasoactive</json:string>
<json:string>homeostasis</json:string>
<json:string>biomedical</json:string>
<json:string>apoptotic</json:string>
<json:string>lymphocyte</json:string>
<json:string>bmdcs</json:string>
<json:string>melanoma cells</json:string>
<json:string>neuroendocrine</json:string>
<json:string>extracellular</json:string>
<json:string>charite</json:string>
<json:string>immunomodulatory</json:string>
<json:string>endocrine</json:string>
<json:string>keratinocyte</json:string>
<json:string>nervous system</json:string>
<json:string>acth</json:string>
<json:string>activates</json:string>
<json:string>nerve fibres</json:string>
<json:string>mitf</json:string>
<json:string>biomedical sciences</json:string>
<json:string>dendricity</json:string>
<json:string>autoimmune</json:string>
<json:string>hair growth</json:string>
<json:string>nerve growth factor</json:string>
<json:string>human sebocytes</json:string>
<json:string>epithelial</json:string>
<json:string>bohm1</json:string>
<json:string>important role</json:string>
<json:string>dermal microvascular</json:string>
<json:string>hyperalgesia</json:string>
<json:string>mast cells</json:string>
<json:string>ludwig boltzmann institute</json:string>
<json:string>insr</json:string>
<json:string>modulators</json:string>
<json:string>adrenomedullin</json:string>
<json:string>hdmec</json:string>
<json:string>transgenic mice</json:string>
<json:string>neurotrophic factor</json:string>
<json:string>healthy subjects</json:string>
<json:string>immune response</json:string>
<json:string>wound healing</json:string>
<json:string>neutral endopeptidase</json:string>
<json:string>dendritic cells</json:string>
<json:string>endogenous</json:string>
<json:string>regulator</json:string>
<json:string>functional role</json:string>
<json:string>immune system</json:string>
<json:string>human hair follicle</json:string>
<json:string>nerve fibers</json:string>
<json:string>rheumatoid arthritis</json:string>
<json:string>allergic dermatitis</json:string>
<json:string>vellus hair follicles</json:string>
<json:string>sebaceous gland</json:string>
<json:string>intracellular calcium concentration</json:string>
<json:string>plasma membrane</json:string>
<json:string>present study</json:string>
<json:string>peripheral blood eosinophils</json:string>
<json:string>costimulatory molecules</json:string>
<json:string>internal medicine</json:string>
<json:string>melanocortin receptors</json:string>
<json:string>hair follicles</json:string>
<json:string>uremic pruritus</json:string>
<json:string>adhesion</json:string>
<json:string>ligand</json:string>
<json:string>boltzmann</json:string>
<json:string>hair buds</json:string>
<json:string>plasma leakage</json:string>
<json:string>cell surface</json:string>
<json:string>epidermal growth factor</json:string>
<json:string>growth factors</json:string>
<json:string>autoimmune diseases</json:string>
<json:string>human melanocytes</json:string>
<json:string>northwestern university</json:string>
<json:string>hair cycle</json:string>
<json:string>merkel cells</json:string>
<json:string>first time</json:string>
<json:string>skin cells</json:string>
<json:string>molecular biology</json:string>
<json:string>contact dermatitis</json:string>
<json:string>adaptive immunity</json:string>
<json:string>inflammatory responses</json:string>
<json:string>schwann cells</json:string>
<json:string>topical application</json:string>
<json:string>oxidative stress</json:string>
<json:string>human keratinocytes</json:string>
<json:string>crucial role</json:string>
<json:string>reconstructed skin</json:string>
<json:string>cell death</json:string>
<json:string>plasma extravasation</json:string>
<json:string>stratum corneum</json:string>
<json:string>anagen hair follicles</json:string>
<json:string>various skin diseases</json:string>
<json:string>neuronal</json:string>
<json:string>afferent</json:string>
<json:string>ethanol</json:string>
<json:string>mouse</json:string>
<json:string>physiology</json:string>
<json:string>proliferation</json:string>
<json:string>allergic</json:string>
<json:string>epidermis</json:string>
<json:string>blood vessels</json:string>
<json:string>melanocyte dendricity</json:string>
<json:string>university hospital</json:string>
<json:string>melanocyte differentiation</json:string>
<json:string>adverse events</json:string>
<json:string>skin cancer</json:string>
<json:string>pivotal role</json:string>
<json:string>human hair growth</json:string>
<json:string>hapten uptake</json:string>
<json:string>intercellular adhesion</json:string>
<json:string>hair growth cycle</json:string>
<json:string>public health</json:string>
<json:string>functional absence</json:string>
<json:string>proteolytic peptidases</json:string>
<json:string>lesional skin</json:string>
<json:string>transcription factors</json:string>
<json:string>respiratory burst</json:string>
<json:string>protein expression</json:string>
<json:string>prurigo nodularis</json:string>
<json:string>significant increase</json:string>
<json:string>proinflammatory cytokines</json:string>
<json:string>epidermal cells</json:string>
<json:string>sensorial neurons</json:string>
<json:string>dorsal root ganglia</json:string>
<json:string>cell proliferation</json:string>
<json:string>protein level</json:string>
<json:string>sebaceous glands</json:string>
<json:string>molecular medicine</json:string>
<json:string>nmda receptors</json:string>
<json:string>postnatal development</json:string>
<json:string>glutamine synthetase</json:string>
<json:string>cutaneous expression</json:string>
<json:string>dermal papilla</json:string>
<json:string>terminal schwann cells</json:string>
<json:string>protein kinase</json:string>
<json:string>nk1r trafficking</json:string>
<json:string>hacat keratinocytes</json:string>
<json:string>human epidermis</json:string>
<json:string>university medicine berlin</json:string>
<json:string>neuropeptide substance</json:string>
<json:string>hair loss</json:string>
<json:string>contact hypersensitivity</json:string>
<json:string>humboldt university</json:string>
<json:string>sigma receptors</json:string>
<json:string>high concentrations</json:string>
<json:string>human fibroblasts</json:string>
<json:string>hair follicle growth</json:string>
<json:string>hair fibre elongation</json:string>
<json:string>hair manner</json:string>
<json:string>western blot</json:string>
<json:string>capsaicin cytotoxicity</json:string>
<json:string>human terminal</json:string>
<json:string>receptor system</json:string>
<json:string>mrna expression</json:string>
<json:string>avena rhealba1</json:string>
<json:string>morphine modulation</json:string>
<json:string>urocortin peptides</json:string>
<json:string>cutaneous neurogenic inflammation</json:string>
<json:string>other hand</json:string>
<json:string>several neuropeptides</json:string>
<json:string>skin inflammation</json:string>
<json:string>dermal fibroblasts</json:string>
<json:string>inhibitor</json:string>
<json:string>activation</json:string>
<json:string>antagonist</json:string>
<json:string>mast</json:string>
<json:string>molecule</json:string>
<json:string>cell</json:string>
<json:string>cultured</json:string>
<json:string>vivo</json:string>
<json:string>skin</json:string>
<json:string>nerve</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>D. J. Tobin</name>
<affiliations>
<json:string>Department of Biomedical Sciences, University of Bradford, Bradford, UK</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>EXD212J</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>abstract</json:string>
</originalGenre>
<abstract>Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides in vitro. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the in situ expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth. In toto, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.</abstract>
<qualityIndicators>
<score>8</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>1765</abstractCharCount>
<pdfWordCount>23570</pdfWordCount>
<pdfCharCount>158516</pdfCharCount>
<pdfPageCount>25</pdfPageCount>
<abstractWordCount>258</abstractWordCount>
</qualityIndicators>
<title>Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<genre>
<json:string>abstract</json:string>
</genre>
<host>
<title>Experimental Dermatology</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1111/(ISSN)1600-0625</json:string>
</doi>
<issn>
<json:string>0906-6705</json:string>
</issn>
<eissn>
<json:string>1600-0625</json:string>
</eissn>
<publisherId>
<json:string>EXD</json:string>
</publisherId>
<volume>13</volume>
<issue>9</issue>
<pages>
<first>569</first>
<last>569</last>
<total>1</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>dermatology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>dermatology & venereal diseases</json:string>
</scienceMetrix>
<inist>
<json:string>sciences appliquees, technologies et medecines</json:string>
<json:string>sciences biologiques et medicales</json:string>
<json:string>sciences medicales</json:string>
<json:string>dermatologie</json:string>
</inist>
</categories>
<publicationDate>2004</publicationDate>
<copyrightDate>2004</copyrightDate>
<doi>
<json:string>10.1111/j.0906-6705.2004.0212j.x</json:string>
</doi>
<id>A29E36D2DF4EE53D92948B9C8EE481D49D1CD779</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/A29E36D2DF4EE53D92948B9C8EE481D49D1CD779/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/A29E36D2DF4EE53D92948B9C8EE481D49D1CD779/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/A29E36D2DF4EE53D92948B9C8EE481D49D1CD779/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<respStmt>
<resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
<respStmt>
<resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd/Inc.</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2004</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<author xml:id="author-1">
<persName>
<forename type="first">D. J.</forename>
<surname>Tobin</surname>
</persName>
<affiliation>Department of Biomedical Sciences, University of Bradford, Bradford, UK</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Experimental Dermatology</title>
<idno type="pISSN">0906-6705</idno>
<idno type="eISSN">1600-0625</idno>
<idno type="DOI">10.1111/(ISSN)1600-0625</idno>
<imprint>
<publisher>Blackwell Publishing Ltd/Inc.</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<date type="published" when="2004-09"></date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="569">569</biblScope>
<biblScope unit="page" to="569">569</biblScope>
</imprint>
</monogr>
<idno type="istex">A29E36D2DF4EE53D92948B9C8EE481D49D1CD779</idno>
<idno type="DOI">10.1111/j.0906-6705.2004.0212j.x</idno>
<idno type="ArticleID">EXD212J</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2004</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides in vitro. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the in situ expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth. In toto, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.</p>
</abstract>
</profileDesc>
<revisionDesc>
<change when="2004-09">Published</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-12-14">References added</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-02-9">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/A29E36D2DF4EE53D92948B9C8EE481D49D1CD779/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley component found">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Ltd/Inc.</publisherName>
<publisherLoc>Oxford, UK; Malden, USA</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1600-0625</doi>
<issn type="print">0906-6705</issn>
<issn type="electronic">1600-0625</issn>
<idGroup>
<id type="product" value="EXD"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="EXPERIMENTAL DERMATOLOGY">Experimental Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="09009">
<doi origin="wiley">10.1111/exd.2004.13.issue-9</doi>
<numberingGroup>
<numbering type="journalVolume" number="13">13</numbering>
<numbering type="journalIssue" number="9">9</numbering>
</numberingGroup>
<coverDate startDate="2004-09">September 2004</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="abstract" position="0056900" status="forIssue">
<doi origin="wiley">10.1111/j.0906-6705.2004.0212j.x</doi>
<idGroup>
<id type="unit" value="EXD212J"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="1"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">Abstracts</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2008-06-28"></event>
<event type="publishedOnlineFinalForm" date="2008-06-28"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.15 mode:FullText source:Header result:Header" date="2010-07-19"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-25"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-17"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="569">569</numbering>
<numbering type="pageLast" number="569">569</numbering>
</numberingGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:EXD.EXD212j.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="0"></count>
<count type="wordTotal" number="2708"></count>
<count type="linksPubMed" number="0"></count>
<count type="linksCrossRef" number="0"></count>
</countGroup>
<titleGroup>
<title type="main">Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
<title type="shortAuthors">
<b>Abstracts</b>
</title>
<title type="short">
<b>Abstracts</b>
</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#a1">
<personName>
<givenNames>D. J.</givenNames>
<familyName>Tobin</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="a1" countryCode="GB">
<unparsedAffiliation>
<b>Department of Biomedical Sciences, University of Bradford, Bradford, UK</b>
</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<p>Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides
<i>in vitro</i>
. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the
<i>in situ</i>
expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth.
<i>In toto</i>
, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Abstracts</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation</title>
</titleInfo>
<name type="personal">
<namePart type="given">D. J.</namePart>
<namePart type="family">Tobin</namePart>
<affiliation>Department of Biomedical Sciences, University of Bradford, Bradford, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="abstract" displayLabel="abstract"></genre>
<originInfo>
<publisher>Blackwell Publishing Ltd/Inc.</publisher>
<place>
<placeTerm type="text">Oxford, UK; Malden, USA</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2004-09</dateIssued>
<copyrightDate encoding="w3cdtf">2004</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="words">2708</extent>
</physicalDescription>
<abstract lang="en">Human skin provides for the local cleavage of pro‐opiomelanocortin (POMC) to yield multiple peptide products, e.g. α‐MSH, ACTH and β‐endorphin (β‐end). α‐MSH and ACTH are well documented to regulate human skin pigmentation. We have recently shown that human epidermal melanocytes express a fully functioning β‐end/µ‐opiate receptor system, and that β‐end has potent melanogenic, mitogenic and dendritogenic effects in cultured epidermal melanocytes. However, little is known about their role in human hair follicle (HF) biology. We have characterized the expression and regulation of β‐end, ACTH, α‐MSH and their receptors in human haired scalp and in cultured HF melanocytes, keratinocytes and fibroblasts by immunochemistry, detection of mRNA transcripts and by assessment of potential melanogenic, dendritogenic and mitogenic effects of these peptides in vitro. These studies show that the POMC peptide system is expressed in HF cells as a function of their anatomic location and differentiation status during the hair growth cycle. All three peptides exhibit similar melanogenic, mitogenic and dendritogenic effects in cultured HF melanocytes. Moreover, while the in situ expression profiles of ACTH and α‐MSH are similar, they differ strikingly from β‐end for all follicular cell populations. One such example is the persistent expression of the former in the hair inductive follicular papilla (FP) throughout the entire hair cycle (but are expressed variably in HF keratinocytes and melanocytes). However, β‐end expression is low to undetectable in the FP during hair growth. In toto, these results indicate that POMC peptides are involved in regulating human HF growth and pigmentation and that alterations in POMC homeostasis may be contribute to pathology.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Experimental Dermatology</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0906-6705</identifier>
<identifier type="eISSN">1600-0625</identifier>
<identifier type="DOI">10.1111/(ISSN)1600-0625</identifier>
<identifier type="PublisherID">EXD</identifier>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>13</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>9</number>
</detail>
<extent unit="pages">
<start>569</start>
<end>569</end>
<total>1</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">A29E36D2DF4EE53D92948B9C8EE481D49D1CD779</identifier>
<identifier type="DOI">10.1111/j.0906-6705.2004.0212j.x</identifier>
<identifier type="ArticleID">EXD212J</identifier>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd/Inc.</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001099 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001099 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sarre
   |area=    MusicSarreV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:A29E36D2DF4EE53D92948B9C8EE481D49D1CD779
   |texte=   Expression and regulation of pro‐opiomelanocortin‐derived peptides in human hair growth and pigmentation
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sun Jul 15 18:16:09 2018. Site generation: Tue Mar 5 19:21:25 2024